and Molecular Diagnostics,
8th Edition by Nader Rifai, PhD
Chapters 1 - 49
,Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics 8th Edition Test Bank
Table of contents:
I. Principles Of Laboratory Medicine
Chapter 1. Clinical Chemistry, Molecular Diagnostics, and Laboratory Medicine
Chapter 2. Selection and Analytical Evaluation of Methods — With Statistical Techniques
Chapter 3. Clinical Evaluation of Methods
Chapter 4. Evidence-Based Laboratory Medicine
Chapter 5. Establishment and Use of Reference Values
Chapter 6. Specimen Collection, Processing, and Other Preanalytical Variables
Chapter 7. Quality Management
II. Analytical Techniques And Instrumentation
Chapter 8. Principles of Basic Techniques and Laboratory Safety
Chapter 9. Optical Techniques
Chapter 10. Electrochemistry and Chemical Sensors
Chapter 11. Electrophoresis
Chapter 12. Chromatography
Chapter 13. Mass Spectrometry
Chapter 14. Enzyme and Rate Analyses
Chapter 15. Immunochemical Techniques
Chapter 16 Automation
Chapter 17. Point-of-Care Instrumentation
III. Analytes
Chapter 18. Amino Acids, Peptides, and Proteins
Chapter 19. Serum Enzymes
Chapter 20. Tumor Markers and Cancer Genes
Chapter 21. Kidney Function Tests — Creatinine, GFR, Urea, and Uric Acid
Chapter 22. Carbohydrates
Chapter 23. Lipids, Lipoproteins, Apolipoproteins, and Other Cardiac Risk Factors
Chapter 24. Electrolytes and Blood Gases
Chapter 25. Hormones
Chapter 26. Catecholamines and Serotonin
Chapter 27. Vitamins, Trace Elements, Nutritional Assessment
Chapter 28. Hemoglobin, Iron, and Bilirubin
Chapter 29. Porphyrins and Porphyrias
Chapter 30. Therapeutic Drugs and Their Management
Chapter 31. Clinical Toxicology
Chapter 32. Toxic Metals
IV. Pathophysiology
Chapter 33. Diabetes
,Chapter 34. Cardiovascular Disease
Chapter 35. Kidney Disease
Chapter 36. Physiology and Disorders of Water, Electrolyte, and Acid-Base Metabolism
Chapter 37. Liver Disease
Chapter 38. Gastrointestinal and Pancreatic Diseases
Chapter 39. Disorders of Bone and Mineral Metabolism
Chapter 40. Disorders of the Pituitary Gland
Chapter 41. Disorders of the Adrenal Cortex
Chapter 42. Thyroid Disorders
Chapter 43. Reproduction-Related Disorders
Chapter 44. Pregnancy and Prenatal Testing
Chapter 45. Newborn Screening and Inborn Errors of Metabolism
Chapter 46. Pharmacogenetics
V. Molecular Diagnostics
Chapter 47. Principles of Molecular Biology
Chapter 48. Nucleic Acid Techniques and Applications
Chapter 49. Genomes and Nucleic Acid Alterations
, Chapter K01: KClinical KChemistry, KMolecular KDiagnostics, Kand KLaboratory
KMedicine KTestKBank
MULTIPLE KCHOICE
1. An Kindividual Kworking Kin Ka Kclinical Kchemistry Klaboratory Kis Kmarried Kto Ka Ksales
Krepresentative Kwho Kworks Kfor Ka Kcompany Kthat Ksells Kchemistry Klaboratory Ksupplies.
KWhen Kthe Klaboratory Kmanager Krequests Ka Klist Kof Kneeded Ksupplies, Kcost Kof Ksupplies,
recommends Kthe Kspouse’s Kcompany Kas Kthe Kvendor.
Kand Kvendors, Kthis Kindividual KonlyK
KThis Kis Kconsidered Kto Kbe Ka(n):
a. accounting Kissue.
b. possible Kconflict Kof Kinterest.
c. maintenance Kof Kconfidentiality Kissue.
d. problem Kwith Kresource Kallocation.
ANS: K B
Concern Khas Kbeen Kraised Kover Kthe Kinterrelationships Kbetween Kpractitioners Kin Kthe
Kmedical KfieldKand Kcommercial Ksuppliers Kof Kdrugs, Kdevices, Kequipment, Ketc., Kto Kthe
Kmedical Kprofession.
Similarly, Krelationships Khave Kbeen Kscrutinized Kbetween Kclinical Klaboratorians Kand
Kmanufacturers Kand Kproviders Kof Kdiagnostic Kequipment Kand Ksupplies. KThese Kconcerns Kled
Kthe KNational KInstitutes Kof KHealth K(NIH) Kin K1995 Kto Krequire Kofficial Kinstitutional Kreview
Kof Kfinancial Kdisclosure Kby Kresearchers Kand Kmanagement Kof Ksituations Kin Kwhich
Kdisclosure Kindicates KpotentialKconflicts Kof Kinterest.
DIF: 1 REF: K K KPage K4-5 OBJ: K 6 K| K7
2. A Kpatient Kvisits Kher Kphysician Kstating Kthat Kher Kprescribed Kpainkiller Kis Knot Kworking Kto
Kreduce Kthe Kpain Kfollowing Kher Krecent Ksurgery. KA Kfriend Kof Kthe Kpatient Kclaims Kthat
Kthe Ksame KpainkillerK“worked Kwonders” Kto Kreduce Kher Kpain Kafter Kthe Ksame Ksurgery.
KThe Kphysician Kstates Kthat Kthe Kdifference Kin Kthe Keffect Kof Kthe Kdrug Kmight Kbe Kcaused
Kby , Kwhich Kis Kstudied Kin
Kpharmacogenetics.
a. epidemiology
b. an Kinherited Kdisease
c. a Kconflict Kof Kinterest
d. a Kgenetic Kvariation Kin Kdrug-metabolizing Kenzymes
ANS: K D
Pharmacogenetics Kis Kthe Kstudy Kof Kthe Kgenetic Kvariation Kof Kdrug Kmetabolism
KbetweenK
individuals.
DIF: 1 REF: K K KPage K3 OBJ: K 1
3. John Kworks Kin Ka Kmolecular Kdiagnostics Klaboratory Kand Kreceives Ka Kblood Ksample Kthat
Khas Kthe Kname Kof Ka Kclose Kfriend Kprinted Kon Kthe Kbar-coded Klabel. KThe Kgenetic Ktest Kthat
Kis Kordered Kon KtheKfriend’s Ksample Kwould Kprovide Kdiagnostic Kinformation Kabout Ka
Kdisorder Kthat Khas Ka Kpoor Kprognosis, Kand Kthe Ktest Kis Kusually Kperformed Kby KJohn. KHe
Kasks Ka Kfellow Kemployee Kto KanalyzeK the Ksample Kfor Khim Kand Knot Kdivulge Kthe Kresults.
KThis Kethical Kissue Kconcerns:
a. confidentiality Kof Kpatient Kgenetic Kand Kmedical Kinformation.
b. a Kconflict Kof Kinterest.
c. resource Kallocation.
d. diagnostic Kaccuracy.